Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer.

Journal of Cancer Research and Clinical Oncology
F PorzsoltH Schönenberger

Abstract

Several investigators have discussed the possible combination of tamoxifen and interferon (IFN) in the treatment of breast cancer patients. The rationale in combining these drugs is that IFN induces the expression of estrogen receptors and therefore increases the sensitivity of breast cancer cells toward the growth-inhibitory activity of tamoxifen. In this paper we review the literature on the IFN-mediated expression of estrogen receptors and the postulated synergism of tamoxifen and IFN in the growth inhibition of breast cancer cell lines. Our results indicate that neither type I nor type II IFN increases the expression of estrogen receptors in MCF-7 cells. Together with tamoxifen both type I and type II IFN mediate additive but not synergistic growth inhibition of MCF-7 cells. On the basis of these results it is feasible to test tamoxifen and IFN as combined therapy in breast cancer patients. Preliminary clinical data show that the combination of 30 mg tamoxifen and 2 x 10(6) IU IFN-alpha as daily doses may induce WHO grade 3 leukopenia and thrombopenia in patients who are pretreated with polychemotherapy.

References

Jan 1, 1985·Investigational New Drugs·B K BhuyanS L Crampton
Dec 29, 1988·The New England Journal of Medicine·UNKNOWN Early Breast Cancer Trialists' Collaborative Group
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·J WagstaffD Crowther
Aug 1, 1985·European Journal of Cancer & Clinical Oncology·N Olea-SerranoJ C Heuson
Jan 5, 1984·The New England Journal of Medicine·J R QuesadaJ U Gutterman

❮ Previous
Next ❯

Citations

Feb 25, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·F RecchiaG Sica
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G SicaA Zaniboni
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J H MartinH W van den Berg
Jul 1, 1997·Journal of Clinical Nursing·J R Cutcliffe
Dec 24, 2019·Journal of Clinical and Experimental Hematopathology : JCEH·Shuntaro Saito, Tsutomu Takeuchi
Jul 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·F RecchiaL Frati
Mar 21, 2002·Cancer Investigation·William K OhMatthew R Smith
Dec 24, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D J Lindner, E C Borden
Jan 1, 1992·Critical Reviews in Oncology/hematology·R ClarkeM E Lippman

❮ Previous
Next ❯

Related Concepts